142 varieties called out of the health insurance point announced! Involved in a number of over a billion varieties.

Pharmaceutical Network, June 24
June 23, Sichuan issued a notice on the transfer of some drugs out of the Sichuan Province Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog (2018 Edition) (hereinafter referred to as "Notice"), will be divided into three time nodes to transfer 142 varietiesAmong them, 6 kinds of drugs, such as conversion sugar electrolyte injections, which are included in the scope of national key monitoring, will be transferred from July 1, 2020, 92 drugs such as domifen tablets will be transferred from August 1, 2020, and 44 drugs such as aluminum magnesium tablets (II) will be transferred from August 1, 2021.Strict implementation of thedrugtransfer time limit
shall not change the variety of their own
according to the provisions of the State Medical Insurance Bureau, for the original provincial drug catalog in accordance with the provisions of the increase of Class B drugs, should be gradually digested within three years, into the scope of national key control drugs should be priority transfer out of the scope of paymentSubsequently, the State Medical Insurance Bureau further clarified the drug digestion schedule, the focus of monitoring range of varieties transfer time requirements.It is understood that according to the national medical insurance bureau clearly defined the transfer time limit, Sichuan decided to be included in the scope of national key monitoring of the conversion of sugar electrolyte injections and other six drugs will be transferred from July 1, 2020.At the same time, 94 drugs, such as domifen tablets, were transferred from August 1, 2020 However, since then, the Sichuan Health Insurance Bureau issued a supplementary notice that, in order to further do a good job in the medical insurance catalog drug transfer work, to ensure the continuity of drug use of insured personnel, after verification of the relevant drug recruitment data, decided to compound sodium acetate sodium linkin injection, compound Lidoka injection two drugs temporarily not transferred out of the Sichuan health insurance catalog The remaining 92 kinds of drugs transferred are in recent years in Sichuan Province pharmaceutical procurement platform basically no network or procurement data varieties, transferred out of the medical insurance catalog on clinical drug use has little impact .　　In addition, 44 kinds of drugs, such as aluminum magnesium tablets (II), are "The Sichuan Provincial Human Resources and Social Security Department on the implementation of the Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog (2018 edition) of Sichuan Province" notice on the implementation of the "Chuan People's Social Development (2018) No 30) provisions of the implementation of reimbursement of drugs." At present, the insured personnel and some medical institutions are still in use, in order to ensure the continuity of drug use of insured personnel, support pharmaceutical enterprises resume work and epidemic prevention and control, give a certain buffer time, from August 1, 2021 to transfer out of the medical insurance directory .　　The Notice emphasizes that the time limit for drug transfer will be strictly enforced in accordance with the deployment requirements of the State Medical Insurance Administration for the gradual digestion of the additional Class B drugs in the original provincial drug catalogue The work of drug transfer is of great significance for regulating the adjustment of the drug catalogue and gradually realizing the unification of the scope of medical insurance drug use throughout the country All localities should attach great importance to, strictly in accordance with the provisions of this notice to transfer out of the varieties and time limit senforcement, may not change the transfer of varieties and time limits .　　Combed out the catalog of varieties found that the varieties are mainly chinese traditional medicine and injections Among them, the conversion of sugar electrolyte injections and other 6 drugs are more than 1 billion varieties According to The Net data, in 2019, sales growth rates in six varieties of public medical facilities in China were negative, with injection compound coenzymes declining by more than 30% It is understood that the injection of compound coenzyme is the exclusive product of Beijing Shuangyu Pharmaceuticals, entered the health insurance catalog in 21 provinces, 2013-2016 sales of the product slowly climbed from 3.6 billion yuan to 4.3 billion yuan, in 2017 began to decline, in 2019 directly fell to 1.86 billion yuan, the rate of decline in the near three years peak .　　The national health insurance bureau has explicitly requested that the number
of Class B drugs added in the original provincial drug catalogue should be transferred out at the rate of 40%, 40% and 20% of the additional quantities in the provinces within three years Recently, the State Medical Insurance Administration issued in the "on doing a good job in 2020 urban and rural residents of basic medical security work notice" stressed that to strengthen the management of medical insurance catalog, the formulation of the provinces to supplement the three-year digestion plan, by the end of June 2020 the national key monitoring varieties out of the catalog and complete the digestion of 40% of the provincial supplementary varieties .　　At present, Beijing, Shandong, Guangdong, Anhui and other provinces have begun to local health insurance catalog additions to the transfer of work Not long ago, the Chongqing Municipal Health Insurance Bureau issued "on the gradual digestion of the local supplement of the list of health insurance Class B drugs in Chongqing", proposed to gradually digest 380 local supplements of the health insurance Class B drugs within three years Of these, 181 will be transferred in 2020, 110 in 2021 and 89 in 2022 On June 4, Guangxi Medical Insurance Bureau also issued a notice, from June 1 to transfer 44 Traditional Chinese medicine and 148 Western medicine out of the provincial health insurance directory It is believed that more and more provinces will announce the transfer catalogue in the future .　　According to Minnet.com, in 2019, 37 local health insurance catalog se-ends in China's public hospital
s, county-level public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) generated sales of more than 1 billion yuan, with total sales of 76.9 billion yuan in 2019 Among them, Dizosin injection sales in 2019 reached 6.78 billion yuan, as many as 20 additional provinces .　　With the provinces to transfer out of the province's health insurance supplements, will bring great pressure on the sale of these varieties Some people in the industry believe that if the transfer of varieties have OTC operating properties, you can also consider the transformation of OTC channels, and some non-competitive varieties may be directly suspended, or choose to cultivate new into the health insurance varieties .　　On July 2020
the varieties will be transferred the
varieties will be transferred from august 2020
note: compound sodium acetate injection, compound lidocarin injection in the supplementary notice decided not to transfer the of the variety from August 1, 2021 .